ビジネス · 2016/2/21 分で読めます
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; General Licensing Provisions; Section 351(k) Biosimilar Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "General Licensing Provisions; Section 351(k) Biosimilar Applications" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.